Publications by authors named "Yongping Cui"

Objectives: Resistance to apoptosis in esophageal squamous cell carcinoma (ESCC) constitutes a significant impediment to treatment efficacy. Exploring alternative cell death pathways and their regulatory factors beyond apoptosis is crucial for overcoming drug resistance and enhancing therapeutic outcomes in ESCC.

Methods: Mammalian Ste 20-like kinase 1 (MST1) is implicated in regulating various cell deaths, including apoptosis, autophagy, and pyroptosis.

View Article and Find Full Text PDF

Esophageal squamous cell carcinoma (ESCC) is a common malignancy, characterized by a multistep pathogenic process regulated spatiotemporally within the esophageal epithelial microenvironment, including vessel normalization and immune infiltration. However, empirical evidence elucidating esophageal vascular remodeling and immune infiltration during ESCC tumorigenesis is lacking. In this study, utilizing a mouse model recapitulating progressive human ESCC stages, we established a tissue clearing workflow for three-dimensional visualization and analysis of esophageal vessels and T cell distribution.

View Article and Find Full Text PDF
Article Synopsis
  • Aberrant glycosylation is a key feature of cancer, but the specific glycogenes involved in esophageal squamous cell carcinoma (ESCC) remain largely unidentified, prompting this research.
  • The study utilized various methods, including genomic analysis and experiments on cell proliferation and metastasis, to evaluate the impact of the glycogenes POFUT1 and RPN1 in ESCC.
  • Results showed that increased expression of POFUT1 and RPN1 correlates with worse patient outcomes and enhanced cancer progression, with POFUT1 influencing migration through the Notch signaling pathway, suggesting both glycogenes as potential targets for cancer treatment in ESCC.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the slow progression and rapid recurrence of esophageal squamous dysplasia (ESD) in some patients, aiming to understand the underlying molecular mechanisms.
  • - Researchers sequenced genomic data from 160 clinical samples and found that ESD has lower mutation and copy number alteration levels compared to esophageal squamous cell carcinoma (ESCC).
  • - They identified a new driver gene related to ESD progression and found that miR-4292 could act as a non-invasive diagnostic marker, offering insights for early diagnosis and better identification of high-risk patients.
View Article and Find Full Text PDF

Esophageal squamous cell carcinoma (ESCC) is a poor-prognostic cancer type with extensive intra- and inter-patient heterogeneity in both genomic variations and tumor microenvironment (TME). However, the patterns and drivers of spatial genomic and microenvironmental heterogeneity of ESCC remain largely unknown. Here, we generated a spatial multi-omic atlas by whole-exome, transcriptome, and methylome sequencing of 507 tumor samples from 103 patients.

View Article and Find Full Text PDF
Article Synopsis
  • Mitochondria, the powerhouses of cells, play an important role in cancer, but scientists know little about how mitochondrial DNA (mtDNA) affects esophageal squamous cell carcinoma (ESCC).
  • New methods were developed to better study mtDNA and its links to ESCC, using data from samples of tumors and normal tissues.
  • The research found that higher amounts of mtDNA in tumors could be linked to how well patients survive and that changes in certain genes might help cancer cells survive in low-oxygen conditions.
View Article and Find Full Text PDF

Tumor-infiltrating B-lineage cells have become predictors of prognosis and immunotherapy responses in various cancers. However, limited knowledge about their infiltration and migration patterns has hindered the understanding of their anti-tumor functions. Here, we examined the immunoglobulin heavy chain (IGH) repertoires in 496 multi-regional tumor, 107 normal tissue, and 48 metastatic lymph node samples obtained from 107 patients with esophageal squamous cell carcinoma (ESCC).

View Article and Find Full Text PDF

DNA methylation is essential for a wide variety of biological processes, yet the development of a highly efficient and robust technology remains a challenge for routine single-cell analysis. We developed a multiplex scalable single-cell reduced representation bisulfite sequencing (msRRBS) technology. It allows cell-specific barcoded DNA fragments of individual cells to be pooled before bisulfite conversion, free of enzymatic modification or physical capture of the DNA ends, and achieves read mapping rates of 62.

View Article and Find Full Text PDF

Esophageal squamous cell carcinoma (ESCC) is a malignant upper digestive tract cancer, and its pathogenesis and etiology are poorly understood. Because gut microbes commonly impact progression, metastasis, and immunotherapy responses in colorectal cancer (CRC), the roles of the esophageal microbiota in ESCC have gradually drawn attention. As reported previously, Fusobacterium nucleatum (Fn), the notable "culprit" of CRC, can also influence the prognosis of ESCC in clinical studies.

View Article and Find Full Text PDF

Integrated molecular analysis of human cancer has yielded molecular classification for precise management of cancer patients. Here, we analyzed the whole genomic, epigenomic, transcriptomic, and proteomic data of 155 esophageal squamous cell carcinomas (ESCCs). Multi-omics analysis led to the classification of ESCCs into four subtypes: cell cycle pathway activation, NRF2 oncogenic activation, immune suppression (IS), and immune modulation (IM).

View Article and Find Full Text PDF

ESCC is a highly malignant tumor, and its morbidity and mortality in China account for more than 50% of the world's total rates. As effective treatments are lacking, the 5-year survival rate of patients does not exceed 30%. CAR-T-cell-based immunotherapy has emerged as one of the most promising cancer treatments; however, there are relatively fewer reports regarding its application for ESCC.

View Article and Find Full Text PDF
Article Synopsis
  • Esophageal squamous cell carcinoma (ESCC) has high genome instability, and a study of 528 whole genomes reveals complex structural variations (SVs) that play crucial roles in its development.* -
  • Researchers identified five types of complex rearrangements, including a notable type called fold-back inversion, which is linked to worse patient outcomes and occurs near genomic structures like the centrosome.* -
  • The study also discovered extrachromosomal circular DNAs (ecDNAs) in 14% of ESCC cases, indicating they provide selective advantages to oncogenes, highlighting the importance of the PTHLH super-enhancer in cancer progression.*
View Article and Find Full Text PDF

Cell division cycle associated 7 (CDCA7) is a copy number amplification gene that contributes to the metastasis and invasion of tumors, including esophageal squamous cell carcinoma (ESCC). This present study aimed at clarifying whether high expression of CDCA7 promotes the metastasis and invasion of ESCC cell lines and exploring the underlying mechanisms implicated in epithelial-mesenchymal transition (EMT) of ESCC. The role of CDCA7 in the regulation of ESCC metastasis and invasion was evaluated using ESCC cell lines.

View Article and Find Full Text PDF

Background: Aberrant glycosylation has been recognized as a hallmark of cancer and N-glycosylation is one of the main types of glycosylation in eukaryotes. Although N-glycoproteomics has made contributions to the discovery of biomarkers in a variety of cancers, less is known about the abnormal glycosylation signatures in esophageal squamous cell carcinoma (ESCC).

Methods: In this study, we reported the proteomics and N-glycoproteomic site-mapping analysis of eight pairs of ESCC tissues and adjacent normal tissues.

View Article and Find Full Text PDF

The 3' untranslated region (3'-UTR) is the vital element regulating gene expression, but most studies have focused on variations in RNA-binding proteins (RBPs), miRNAs, alternative polyadenylation (APA) and RNA modifications. To explore the posttranscriptional function of 3'-UTR somatic mutations in tumorigenesis, we collected whole-genome data from 2413 patients across 18 cancer types. Our updated algorithm, PIVar, revealed 25,216 3'-UTR posttranscriptional impairment-related SNVs (3'-UTR piSNVs) spanning 2930 genes; 24 related RBPs were significantly enriched.

View Article and Find Full Text PDF

To construct a prognostic model for preoperative prediction on computed tomography (CT) images of esophageal squamous cell carcinoma (ESCC), we created radiomics signature with high throughput radiomics features extracted from CT images of 272 patients (204 in training and 68 in validation cohort). Multivariable logistic regression was applied to build the radiomics signature and the predictive nomogram model, which was composed of radiomics signature, traditional TNM stage, and clinical features. A total of 21 radiomics features were selected from 954 to build a radiomics signature which was significantly associated with progression-free survival ( < 0.

View Article and Find Full Text PDF

Family with sequence similarity 84, member B (FAM84B) is a significant copy number amplification gene in the 8q24.21 locus identified by our previous WGS study in esophageal squamous cell carcinoma (ESCC). However, its clinical relevance and potential mechanisms have been elusive.

View Article and Find Full Text PDF

Background: Currently, there is no clinically relevant non-invasive biomarker for early detection of esophageal squamous cell carcinoma (ESCC). Herein, we established and evaluated a circulating microRNA (miRNA)-based signature for the early detection of ESCC using a systematic genome-wide miRNA expression profiling analysis.

Methods: We performed miRNA candidate discovery using three ESCC tissue miRNA datasets (n = 108, 238, and 216) and the candidate miRNAs were confirmed in tissue specimens (n = 64) by qRT-PCR.

View Article and Find Full Text PDF

Due to the lack of effective diagnostic markers and therapeutic targets, esophageal squamous cell carcinoma (ESCC) shows a poor 5 years survival rate of less than 30%. To explore the potential therapeutic targets of ESCC, we integrated and reanalyzed the mutation data of WGS (whole genome sequencing) or WES (whole exome sequencing) from a total of 1,145 samples in 7 large ESCC cohorts, including 270 ESCC gene expression data. Two new mutation signatures and 20 driver genes were identified in our study.

View Article and Find Full Text PDF

Background: is a copy number amplified gene identified not only in esophageal squamous cell carcinoma (ESCC) but also in various cancer types. Its clinical relevance and underlying mechanisms in ESCC have remained unknown.

Methods: Tissue microarray data was used to analyze its expression in 179 ESCC samples.

View Article and Find Full Text PDF

Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignant tumors in China, and its prognosis remains poor. Autophagy is an evolutionarily conserved catabolic process involved in the occurrence and development of ESCC. In this study, we described the expression profile of autophagy-related genes (ARGs) in ESCC and developed a prognostic prediction model for ESCC patients based on the expression pattern of ARGs.

View Article and Find Full Text PDF

One dimensional Zn doped CuFe₂O₄ spinel ferrite nanofibers were successfully prepared via a facile electrospinning method followed by two different calcination routes. The results showed that the as-prepared nanofibers through two-step calcination exhibited more uniform size distribution in diameter compared with those calcined by one-step method. X-ray diffraction (XRD) results indicated that with the increase of Zn content the position of diffraction peaks of Zn doped CuFe₂O₄ slightly shift towards lower 2θ angle because the ionic sizes of the Zn (0.

View Article and Find Full Text PDF